Teladoc Health TDOC Selling Expense
Selling Expense at other companies
Other financials
Where this comes from
Reported directly by Teladoc Health in its filing.
Tagged under the XBRL concept us-gaap:SellingExpense.
The official record: Teladoc Health’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Teladoc Health's selling expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Teladoc Health's selling expense?
- Teladoc Health (TDOC) reported selling expense of $51.28M in Q1 2026.
- How has Teladoc Health's selling expense changed year-over-year?
- Teladoc Health's selling expense increased by 5.3% year-over-year, from $48.69M to $51.28M.
- What is the long-term trend for Teladoc Health's selling expense?
- Over 4 years (2021 to 2025), Teladoc Health's selling expense has grown at a -6.1% compound annual growth rate (CAGR), from $250.58M to $194.52M.
- What does selling expense mean?
- This represents the total costs incurred by the company to promote, market, and sell its products or services to customers. It typically includes advertising expenditures, sales force compensation, and related marketing overheads. Monitoring this metric helps investors evaluate the efficiency of customer acquisition strategies and the scalability of the sales model.